×
About 136,336 results

ALLMedicine Schizophrenia Center

Research & Reviews  63,839 results

What you see is what you get: visual scanning failures of naturalistic social scenes in...
https://doi.org/10.1017/S0033291720001646
Psychological Medicine; Patel GH, Arkin SC et. al.

Jun 4th, 2020 - Impairments in social cognition contribute significantly to disability in schizophrenia patients (SzP). Perception of facial expressions is critical for social cognition. Intact perception requires an individual to visually scan a complex dynamic ...

Death anxiety and attitude to death in patients with schizophrenia and depression.
https://doi.org/10.1016/j.psychres.2020.113148
Psychiatry Research; Mavrogiorgou P, Haller K et. al.

Jun 4th, 2020 - Attitude to death and death anxiety in patients with severe psychiatric disorders have been studied rarely so far, although this is an existential perspective for each human being and clinically seems to be changed in patients with depression and ...

A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in...
https://doi.org/10.1371/journal.pone.0234121
PloS One; Mørup MF, Kymes SM et. al.

Jun 4th, 2020 - Schizophrenia is a condition that places a significant burden on individuals with the condition, their family, and society. A large proportion of those treated for schizophrenia do not experience treatment response and are referred to as having "t...

Interactive effect of MTHFR C677T polymorphism and sex on symptoms and cognitive functi...
https://doi.org/10.18632/aging.103248
Aging Gao J, Xiu MH et. al.

Jun 4th, 2020 - The etiology of schizophrenia is still unknown, and the MTHFR gene has been shown to be associated with SCZ. Previous studies have shown that patients with schizophrenia exhibit sex differences in symptoms and cognitive function. However, no study...

GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhib...
https://doi.org/10.1371/journal.pone.0233895
PloS One; Garst-Orozco J, Malik R et. al.

Jun 4th, 2020 - Deficits in fast-spiking inhibitory interneurons (FSINs) within the dorsolateral prefrontal cortex (dlPFC) are hypothesized to underlie cognitive impairment associated with schizophrenia. Though representing a minority of interneurons, this key ce...

see more →

Guidelines  39 results

CAPLYTA® (lumateperone) | Now Approved | caplyta.com‎
https://www.caplyta.com/‎

Jan 13th, 2020 - Learn about a new treatment. See full safety information, PI, and boxed warning. Get information about this orally administered capsule. Press Release. Prescribing Information. MOA. Important Safety Info. Dosing & Administration.

Cannabidiol as a potential treatment for psychosis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6843725/
Therapeutic Advances in Psychopharmacology; Davies C,et al

Nov 7th, 2019 - Psychotic disorders such as schizophrenia are heterogeneous and often debilitating conditions that contribute substantially to the global burden of disease. The introduction of dopamine D2 receptor antagonists in the 1950s revolutionised the treat...

U.S. FDA Approves SECUADO® (asenapine) Transdermal System, the First-and-Only Transdermal Patch for the Treatment of Adults with Schizophrenia
http://www.noven.com/PR101519.php

Oct 14th, 2019 - Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced the U.S. Food and Drug Administration (FDA) has approved SECUADO® (asenapine) transdermal system, the first-and-only transdermal patch fo...

HIV, schizophrenia, and all-cause mortality
https://www.sciencedirect.com/science/article/abs/pii/S0920996419301537?via%3Dihub
Schizophrenia Research;

Jun 26th, 2019 - Schizophrenia is a severe mental illness with important implications for morbidity and mortality. This population-based cohort study examined the impact of schizophrenia diagnoses on all-cause mortality among a sample of people living with HIV (PL...

Switching patients with schizophrenia from paliperidone palmitate to aripiprazole lauroxil: A 6-month, prospective, open-label study
https://www.sciencedirect.com/science/article/pii/S0920996419300416?via%3Dihub
Miller,B.,et al

Feb 6th, 2019 - We assessed the effectiveness of switching from paliperidone palmitate (PP) or risperidone long-acting injection (RLAI) to aripiprazole lauroxil (AL). Prospective, 6-month study in patients with schizophrenia with residual symptoms or intolerance ...

see more →

Drugs  1,459 results see all →

Clinicaltrials.gov  67,593 results

What you see is what you get: visual scanning failures of naturalistic social scenes in...
https://doi.org/10.1017/S0033291720001646
Psychological Medicine; Patel GH, Arkin SC et. al.

Jun 4th, 2020 - Impairments in social cognition contribute significantly to disability in schizophrenia patients (SzP). Perception of facial expressions is critical for social cognition. Intact perception requires an individual to visually scan a complex dynamic ...

Death anxiety and attitude to death in patients with schizophrenia and depression.
https://doi.org/10.1016/j.psychres.2020.113148
Psychiatry Research; Mavrogiorgou P, Haller K et. al.

Jun 4th, 2020 - Attitude to death and death anxiety in patients with severe psychiatric disorders have been studied rarely so far, although this is an existential perspective for each human being and clinically seems to be changed in patients with depression and ...

A modelling approach to estimate the prevalence of treatment-resistant schizophrenia in...
https://doi.org/10.1371/journal.pone.0234121
PloS One; Mørup MF, Kymes SM et. al.

Jun 4th, 2020 - Schizophrenia is a condition that places a significant burden on individuals with the condition, their family, and society. A large proportion of those treated for schizophrenia do not experience treatment response and are referred to as having "t...

Interactive effect of MTHFR C677T polymorphism and sex on symptoms and cognitive functi...
https://doi.org/10.18632/aging.103248
Aging Gao J, Xiu MH et. al.

Jun 4th, 2020 - The etiology of schizophrenia is still unknown, and the MTHFR gene has been shown to be associated with SCZ. Previous studies have shown that patients with schizophrenia exhibit sex differences in symptoms and cognitive function. However, no study...

GluN2D-mediated excitatory drive onto medial prefrontal cortical PV+ fast-spiking inhib...
https://doi.org/10.1371/journal.pone.0233895
PloS One; Garst-Orozco J, Malik R et. al.

Jun 4th, 2020 - Deficits in fast-spiking inhibitory interneurons (FSINs) within the dorsolateral prefrontal cortex (dlPFC) are hypothesized to underlie cognitive impairment associated with schizophrenia. Though representing a minority of interneurons, this key ce...

see more →

News  3,369 results

First-in-Class Antipsychotic Linked to Lower Cardiometabolic Risk
https://www.medscape.com/viewarticle/931666

Jun 2nd, 2020 - A recently approved first-in-class antipsychotic appears to have fewer adverse cardiometabolic effects compared with standard care with risperidone, new research suggests. In post hoc analyses of two short-term randomized controlled trials plus an...

CHMP Backs Generic Paliperidone for Schizophrenia
https://www.medscape.com/viewarticle/929845

May 1st, 2020 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of the antipsychotic Paliperidone Janssen-Cilag International (Janssen-Cilag International N.V.) for the treatment of schizop...

First-in-Class Schizophrenia Drug Safe, Effective, Durable
https://www.medscape.com/viewarticle/928832

Apr 15th, 2020 - A novel first-in-class antipsychotic that has a completely different mechanism of action than other currently available agents shows long-term efficacy and a good safety profile in patients with schizophrenia. SEP-363856 (Sunovion Pharmaceuticals)...

Polygenic Risk Score Predicts Treatment Resistance in Schizophrenia
https://www.medscape.com/viewarticle/927923

Apr 1st, 2020 - NEW YORK (Reuters Health) - A polygenic risk score (PRS) can help predict resistance to treatment with antipsychotic medication in schizophrenia, according to Scandinavian researchers. As Dr. Maren Caroline Frogner Werner of Oslo University Hospit...

Is psychosis toxic to the brain?
https://www.mdedge.com/psychiatry/article/219773/schizophrenia-other-psychotic-disorders/psychosis-toxic-brain?channel=133
Gerald Martone, MS, MSN, PMHNP-BC

Mar 31st, 2020 - Schizophrenia has been described as the “worst disease” to afflict mankind. 1 It causes psychosis, which is an abnormal state of mind marked by hyperarousal, overactivation of brain circuits, and emotional distress.

see more →

Patient Education  37 results see all →